208 related articles for article (PubMed ID: 35283709)
1. Gadolinium Retention after Contrast-Enhanced Magnetic Resonance Imaging: A Narratative Review.
Al-Muhanna AF
Saudi J Med Med Sci; 2022; 10(1):12-18. PubMed ID: 35283709
[TBL] [Abstract][Full Text] [Related]
2. Gadolinium Deposition in Brain: Current Scientific Evidence and Future Perspectives.
Guo BJ; Yang ZL; Zhang LJ
Front Mol Neurosci; 2018; 11():335. PubMed ID: 30294259
[TBL] [Abstract][Full Text] [Related]
3. Brain tissue gadolinium retention in pediatric patients after contrast-enhanced magnetic resonance exams: pathological confirmation.
Stanescu AL; Shaw DW; Murata N; Murata K; Rutledge JC; Maloney E; Maravilla KR
Pediatr Radiol; 2020 Mar; 50(3):388-396. PubMed ID: 31989188
[TBL] [Abstract][Full Text] [Related]
4. The presence of the gadolinium-based contrast agent depositions in the brain and symptoms of gadolinium neurotoxicity - A systematic review.
Olchowy C; Cebulski K; Łasecki M; Chaber R; Olchowy A; Kałwak K; Zaleska-Dorobisz U
PLoS One; 2017; 12(2):e0171704. PubMed ID: 28187173
[TBL] [Abstract][Full Text] [Related]
5. Gadolinium deposition within the dentate nucleus and globus pallidus after repeated administrations of gadolinium-based contrast agents-current status.
Stojanov D; Aracki-Trenkic A; Benedeto-Stojanov D
Neuroradiology; 2016 May; 58(5):433-41. PubMed ID: 26873830
[TBL] [Abstract][Full Text] [Related]
6. Gadolinium deposition in the brain: association with various GBCAs using a generalized additive model.
Bae S; Lee HJ; Han K; Park YW; Choi YS; Ahn SS; Kim J; Lee SK
Eur Radiol; 2017 Aug; 27(8):3353-3361. PubMed ID: 28083696
[TBL] [Abstract][Full Text] [Related]
7. Gadolinium Deposition in Neurology Clinical Practice.
Smith TE; Steven A; Bagert BA
Ochsner J; 2019; 19(1):17-25. PubMed ID: 30983897
[No Abstract] [Full Text] [Related]
8. Gadolinium deposition in the brain.
Kanda T; Nakai Y; Oba H; Toyoda K; Kitajima K; Furui S
Magn Reson Imaging; 2016 Dec; 34(10):1346-1350. PubMed ID: 27613998
[TBL] [Abstract][Full Text] [Related]
9. Effect of at Least 10 Serial Gadobutrol Administrations on Brain Signal Intensity Ratios on T1-Weighted MRI in Children: A Matched Case-Control Study.
Ozturk K; Nascene D
AJR Am J Roentgenol; 2021 Sep; 217(3):753-760. PubMed ID: 33112200
[No Abstract] [Full Text] [Related]
10. Gray Matter Nucleus Hyperintensity After Monthly Triple-Dose Gadopentetate Dimeglumine With Long-term Magnetic Resonance Imaging.
DeBevits JJ; Munbodh R; Bageac D; Wu R; DiCamillo PA; Hu C; Wang L; Naismith RT; Karimeddini D; Dhib-Jalbut S; Redko S; Cook SD; Cadavid D; Wolansky L
Invest Radiol; 2020 Oct; 55(10):629-635. PubMed ID: 32898355
[TBL] [Abstract][Full Text] [Related]
11. Effects of Gadolinium Depositions in Vivo.
Bruno D; Vealé BL
Radiol Technol; 2021 Sep; 93(1):46-54. PubMed ID: 34588278
[TBL] [Abstract][Full Text] [Related]
12. Technical aspects of MRI signal change quantification after gadolinium-based contrast agents' administration.
Ramalho J; Ramalho M; AlObaidy M; Semelka RC
Magn Reson Imaging; 2016 Dec; 34(10):1355-1358. PubMed ID: 27693606
[TBL] [Abstract][Full Text] [Related]
13. High signal intensity in dentate nucleus and globus pallidus on unenhanced T1-weighted MR images in three patients with impaired renal function and vascular calcification.
Barbieri S; Schroeder C; Froehlich JM; Pasch A; Thoeny HC
Contrast Media Mol Imaging; 2016 May; 11(3):245-50. PubMed ID: 26929131
[TBL] [Abstract][Full Text] [Related]
14. Brain gadolinium deposition after administration of gadolinium-based contrast agents.
Kanda T; Oba H; Toyoda K; Kitajima K; Furui S
Jpn J Radiol; 2016 Jan; 34(1):3-9. PubMed ID: 26608061
[TBL] [Abstract][Full Text] [Related]
15. Standardized assessment of the signal intensity increase on unenhanced T1-weighted images in the brain: the European Gadolinium Retention Evaluation Consortium (GREC) Task Force position statement.
Quattrocchi CC; Ramalho J; van der Molen AJ; Rovira À; Radbruch A;
Eur Radiol; 2019 Aug; 29(8):3959-3967. PubMed ID: 30413951
[TBL] [Abstract][Full Text] [Related]
16. Weekly enhanced T1-weighted MRI with Gadobutrol injections in MS patients: Is there a signal intensity increase in the dentate nucleus and the globus pallidus?
Jaulent P; Hannoun S; Kocevar G; Rollot F; Durand-Dubief F; Vukusic S; Brisset JC; Sappey-Marinier D; Cotton F
Eur J Radiol; 2018 Aug; 105():204-208. PubMed ID: 30017281
[TBL] [Abstract][Full Text] [Related]
17. Macrocyclic and Other Non-Group 1 Gadolinium Contrast Agents Deposit Low Levels of Gadolinium in Brain and Bone Tissue: Preliminary Results From 9 Patients With Normal Renal Function.
Murata N; Gonzalez-Cuyar LF; Murata K; Fligner C; Dills R; Hippe D; Maravilla KR
Invest Radiol; 2016 Jul; 51(7):447-53. PubMed ID: 26863577
[TBL] [Abstract][Full Text] [Related]
18. Brain gadolinium deposition, hyperintense MRI signals, and resonance contrast agents.
Costa A; Ronchi A; Pigatto PD; Guzzi G
Magn Reson Imaging; 2018 Oct; 52():137-138. PubMed ID: 29885445
[No Abstract] [Full Text] [Related]
19. Increased signal intensities in the dentate nucleus and globus pallidus on unenhanced T1-weighted images: evidence in children undergoing multiple gadolinium MRI exams.
Hu HH; Pokorney A; Towbin RB; Miller JH
Pediatr Radiol; 2016 Oct; 46(11):1590-8. PubMed ID: 27282825
[TBL] [Abstract][Full Text] [Related]
20. Histology and Gadolinium Distribution in the Rodent Brain After the Administration of Cumulative High Doses of Linear and Macrocyclic Gadolinium-Based Contrast Agents.
Lohrke J; Frisk AL; Frenzel T; Schöckel L; Rosenbruch M; Jost G; Lenhard DC; Sieber MA; Nischwitz V; Küppers A; Pietsch H
Invest Radiol; 2017 Jun; 52(6):324-333. PubMed ID: 28323657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
